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The role of the heme protein P450 in the reaction mechanism 
of steroid hydroxylation can be described as : 
r +~ r 
P450(Fea') -7 P450(Fe2+) -7 P450(Fe2+) · 0 2 -7 P450(Fe3+) 
In the course of this reaction cycle the heme protein undergoes a 
series of changes of its coordination around the Fe (on reduction 
to its »unliganded~ Fe2+ state, on binding of the 0 2 molecule, and 
upon introduction of the second reducing equivalent, as the heme 
protein returns to its original Fe3+ state}. 
Steroid substrates, inhibitors, and a variety of agents bind to 
the heme protein P450(Fe3+), isolated in a S = 1/2 form from bovine 
adrenal glands, with high affinities at sites near the heme group, 
but do not as a rule enter the coordination sphere of the Fe. This 
leads to perturbations of the electronic structure which can be fol-
lowed by spectroscopic techniques (optical absorption, EPR spectro-
scopy) in combination with suitable chemical methods. Direct re-
placement of a ligand can also be achieved. The ferrous heme 
protein P450(Fe2+), in its unliganded and liganded forms, was also 
investigated. P450(Fe2•) combines readily with small ligands such 
as 0 2 (418 nm), CO (448 nm), and nitric oxide. Larger lipophilic 
molecules (e. g. pyridine derivatives, other heterocyclic compounds, 
haloalkanes, or hydroperoxides) also bind readily to P450(Fe2+), 
often with high affinities. They tend to enter the coordination 
sphere of the Fe and form stable complexes often with distinct 
optical absorption (440-470 nm); additional unspecific binding is 
frequently observed. 
Representative examples of the results for the various cases 
of interactions are presented and are discussed in relation to a 
hypothetical structure of P450(Fe3• ), S = 1/2, as a protoheme IX 
complex, with a thiol-group and a N-containing group as axial 
ligands; the observations are further related to the required changes 
in coordination in the course of the hydroxylation reaction. 
INTRe>DUCTION 
The heme protein P450 is the key enzyme of a multienzyme system, 
steroid 11B-hydroxylase (EC 1.14.1.6), which catalyzes the insertion of a 
hydroxyl group into the 11B-position of certain steroid molecules (for a review 
* Presented at the Scientific Conference »Cytochrome P450 - St ructural Aspects« 
(held in Primosten - Yugoslavia, 6--10. October, 1976), by H. S. (to whom the ·cor-
respondence concerning this paper should be addressed). 
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and a selection of references see ref. 1). This multienzyme system is located 
in the mitochondria of the cortex layer of adrenal glands. Several other steroid 
oxygenation reactions in adrenals and other endocrine organs are also catalyzed 
by P450-containing multienzyme systems. 
Similar types of the heme protein P450 are found in the endoplasmic 
reticulum of liver, kidney, lung, intestine, and other mammalian organs. A 
particularly high concentration of the heme protein - especially after induction 
of the animals - makes the liver a favorite source for studies; for a selection 
of pertinent references see ref. 2. From the intracellular structures of the 
endoplasmic reticulum the heme protein P450 is isolated in a membrane-bound 
form in artificially formed vesicles, called microsomes3•4• The heme protein has 
been solubilized from these particulate preparations by the methods reviewed 
in reference 5 (see also refs. 6 and 7) . 
Analogous types of the heme protein P450 are further found in a variety 
of lower animals as well as in higher and lower plants. The best known example 
of the latter group, the so called P450CAM8 (notes 1 and 2) from a D-camphor -
grown mutant of Pseudomonas putida, has been extensively studied9. 
The existence of enzyme systems which are capable of catalyzing a direct 
oxygenation of steroids was demonstrated (cf. refs. 10-14) several years before 
»a new pigment«, named P450, was discovered in microsomal preparations15- 17 . 
The role of this newly discovered pigment as a »terminal oxidase« in steroid 
hydroxylation reactions - a C2chydroxylation being the first case - was 
demonstrated by the methods of photochemical action spectroscopy in 196318. 
These investigations and the independent studies of Omura and Sato19•20 on the 
new pigment in liver microsomes formed the basis for the rapidly expanding 
research on the heme protein P450, its nature and its function as the key 
enzyme in an unsuspected variety of oxygenating reactions. 
The steroid llB-hydroxylase of bovine adrenal glands is the first mam-
malian system of the mixed function oxidase (or monoxygenase) type which 
could be successfully resolved into its individual enzyme components - a 
flavoprotein, Fp (note 1)21 an iron sulfur protein, ISP (note 1)22 •23 and the 
heme protein P450 (notes 1 and 2). These three enzyme components could be 
separated on a preparative scale and at least partially purified; upon recom-
bination the steroid llB-hydroxylase activity could be restored (for detailed 
references see ref. 24). 
Subsequently, a procedure was developed to obtain a soluble purified 
preparation of the heme protein P450 from adrenal cortex mitochondria. This 
preparation has provided us with much of the important chemical and physical 
information about this most atypical heme protein P450. Investigation of its 
properties have led to the determination of the optical absorption spectra of its 
various forms 24 , of its EPR characteristics25 in relation to the earlier observations 
of Mason et al. 26 , the »low spin« (S = 1/2) character of the isolated form of 
the heme protein27 , and its unique oxidation - reduction characteristics25•28• 
In the course of subsequent investigations the cyclic sequence of events which 
constitutes the reaction mechanism of steroid llB-hydroxylation and, by 
analogy, also of other mixed function oxidation (oxygenation) reactions, was 
established. 
Studies on our adrenal P450 preparation led to the somewhat unexpected 
finding of an absolute requirement for the adrenal iron sulfur protein (ISP)23 
in the hydroxylation reaction; this was also found for the soluble camphor 
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methylene hydroxylase system of P. putida. The requirement for a specific ISP 
in the hydroxylation reaction allowed the experimental separation of the 
two sequential one-electron reduction steps in the reaction cycle and, later on, 
led to the detection and partial characterization of an Fe2+ · 0 2 complex of 
the heme protein P45029• This preparation of the heme protein P450 from 
adrenal cortex mitochondria today serves as the basic material for detailed 
physical and chemical studies of its nature, properties, and reactivities in its 
v arious valence states and forms. 
Following a brief review of the steroid llB-hydroxylase system and some 
basic properties of the preparation we describe the reactivities of the heme 
protein P450 from adrenal cortex mitochondria in Fe3+- and Fe2+-forms. Its 
properties are briefly compared with those of P450CAM9 and with P450 pre-
parations from rat and rabbit liver microsomal preparations (see ref. 5 and 
many other contributions to this C. C. A. issue). 
METHODS AND MATERIALS 
Enzyme preparations 
The heme protein P450 is routinely prepared from bovine adrenal cortex mito-
chondria by the method described in ref. 30. Various membrane-bonud forms of t.he 
heme protein P450 are obtained as microsomal preparations from rat liver with or 
without pretreatment of the animals with inducing agents31 . 
Adrenal iron sulfur protein, ISP, is extracted from homogenates of bovine 
adrenal glands, enriched in a batch-type procedure, and purified by anion exchange-
and gel exclusion chromatography. The adrenal flavoprotein, Fp, is prepared ac-
cording to the procedure of ref. 32, which was substantially modified in recent years 
to achieve better preparative yields and higher purities. 
Analytical procedures 
The concentration of the heme protein P450 is determined from the optical 
absorption spectra of solutions of its carbon monoxide complex, P450(Fe2+) · CO, 
after chemical or enzymatic reduction and equilibration with carbon monoxide ; a 
molar absorption coefficient 
Ii (448 nm) = 9.7 · 104 M-1 cm-1 
is used. In the case of turbid materials, such as adrenal mitochondria and microsomal 
preparations, the absorption characteristics of P450(Fe2+) · CO are utilized in difference 
spectroscopy, using a value20 
Ac (450- 490 nm, Fe2+ • CO minus Fe2+) = 9.1 · 104 M1- cm-1. 
The heme content of the various preparations is determined spectrophotometri-
cally after conversion into a Fe2+-pyridine hemochrome complex. Protein concen-
tration is measured with the biuret reaction or an adaptation of the Lowry method. 
Concentrations of ISP and FP are determined spectrophotometrically on the basis 
of their optical absorption spectra. Adrenal ISP is also measured by EPR spectroscopy 
of its reduced form using authentic material as standard for the quantitation. 
Instrumentation 
Optical absorption spectrophotometry is carried out with a Cary recording 
spectrophotometer, model 14, equipped with 0 -1.0 A and 0- 0.1 A slidewires. 
Measurements on turbid samples are made with an Aminco DW-2 spectrophotometer, 
an Aminco-Chance Dual Wavelength spectrophotometer, and a Chance-Young type 
scanning spectrophotometer. 
EPR spectroscopy is performed with a Varian spectrometer system E 9. Inten-
sities, relative to well-characterized standard samples, are obtained by numerical 
double integration procedures33• 
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Anaerobic measurements under strict 0 2-exclusion are performed in specially 
developed equipment built by Dr. Mott Cannon in our laboratories; a slight positive 
pressure of inert oxygen-free carrier gas (N2 or He) is utilized in double chamber 
systems to reduce leakage rates. 
Chemicals 
All chemicals used are of analytical grade or of the highest purity commercially 
available. As necessary they are further purified by conventional techniques (e.g. 
distillation, recrystallization). Doubly quartz-distilled water is used throughout. 
The Steroid 11B-HydroxyLase Reaction: Stoichiometry and Reaction 
Mechanism 
The heme protein P450(Fe3+) as key enzyme of the steroid llB-hydroxylase 
multienzyme system catalyzes the insertion of a hydroxyl group into the 
llB-position of the steroid skeleton in such molecules as deoxycorticosterone 
(Figure 1) . The oxygen atom in the inserted hydroxyl-group is derived from 
~H2 0H ~H2 OH 
C=O C=O 




De oll'.ycorticosterone Corticosterone 
Figure 1. Steroid 11~-hydroxylation. 
atmospheric oxygen; the remaining 0-atom of the 0 2-molecule is reduced 
to water. NADPH serves as the physiological electron donor and provides the 
two reducing equivalents necessary for this reaction (cf. equation (1)). 
R-H + 02 + NADPH + H+-7R-OH + NADP+ + H20 (1) 
In the adrenal cortex mitochondria, the reducing equivalents are channeled 
into the heme protein P450 via a specific electron transport chain which con-
sists of a flavoprotein (Fp) and an iron sulfur protein (ISP) 1 • The flavoprotein, 
Fp, which contains FAD as prosthetic group, has been difficult to obtain in 
sufficient quantities to allow extensive purification and is thus as yet not 
well understood. The adrenal iron sulfur protein, ISP, contains a two Fe -
two »labile sulfur« - active center which is similar to those found in the 
ubiquituous plant ferredoxins. ISP is - as we now know - absolutely neces-
sary for steroid llB-hydroxylation by adrenal P45023 , beyond its simple role 
as member of an electron transport chain. 
An analogous situation, but with NADH as electron source, is found in 
the camphor 5-exo-methylene system from Pseudomonas putida9• In the 
closely related mixed function oxidase (monoxygenation) systems derived from 
the endoplasmic reticulum of mammalian tissues NADPH serves as electron 
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donor. A flavoprotein, the NADPH-P450-reductase, formerly called NADPH-
-cytochrome c-reductase,34 functions as electron carrier; this enzyme contains 
one mole of FAD and one mole of FMN per mole of protein. In contrast to the 
steroid hydroxylase and camphor hydroxylase, details of the electron transport 
system, which supplies reducing equivalents to the heme protein in these 
systems from the endoplasmic reticulum, are not known with certainty. The 
function of cytochrome b5, always found in these preparations, is likewise the 
subject of ongoing controversies (for a recent review see ref. 35). 
The heme protein P450, which catalyzes 0 2-activation and substrate 
hydroxylation, undergoes a cyclic sequence of reaction steps, as shown in 
Figure 2. Each individual step of this reaction cycle has been experimentally 
P,-450(Fe 2 +)·02 
/ \ 
R~H ' 
' ' '- ',_ ~,,/ 






Figure 2. Role of the heme protein P450 in steroid 11~-hydroxylation. 
verified for the steroid 11B-hydroxylase1. Analogous results have been obtained 
by Gunsalus et al. in their studies of the camphor hydroxylase system from P. 
putida9• In the course of the reaction cycle the heme protein P450 assumes 
characteristics of several well-known heme proteins. Starting with the 
P450(Fe3+) as isolated, introduction of the first reducing equivalent leads to the 
formation of »Unliganded« P450(Fe2+) (note 2) in a reversible, one-electron 
reduction process which corresponds to those observed witl:t typical cyto-
chromes. In the following reaction step P450(Fe2+) combines with oxygen to 
form the Fe2+ • 0 2 complex (cf. below for details). This step is similar to, and 
in a formal sense analogous to, the reversible binding of 0 2 to oxygen-carrier 
type heme proteins (hemoglobin or myoglobin). At this point in the reaction 
cycle (Figure 2) the second reducing equivalent is introduced by reduced iron 
sulfur protein ISP as specific electron donor. In an as yet unresolved reaction 
this then leads in an essentially irreversible reaction to formation of product 
(hydroxylated steroid and water) and the return of the heme protein to its 
~ 84 H. SCHLEYER ET AL. 
original form, P450(Fe3+), · S = 1/2. This final reaction step, which concludes 
the cycle of the steroid n~-hydroxylase reaction, is unique for the heme 
protein P450 and has so far not been observed with any other heme protein. 
To this list of similarities of the heme protein P450 with other known heme 
proteins we may have to add as a further mode of action that of a peroxidase, 
based on the capacity of microsomal preparations for hydroperoxide-sup-
ported hydroxylation reactions with a variety of substrates (cf. also below for 
the interaction of the adrenal heme protein P450 with hydroperoxides). A mode 
of action as a special reductase has also been suggested in which electron-
-donating properties of P450(Fe2+) may be utilized in certain cases. In view of 
these multifacetted characteristics we prefer the »generic« name heme protein 
P450 to such terms as cytochrome P450; see also ref. 1. Use of a nomenclature 
based on the structure of the heme group seems not to be justified as yet. 
A nomenclature based'. on the substrate specificity of the catalyzed reactions 
is not applicable for most mammalian preparations. 
The capabilities of carrying out the multitude of different individual 
reactions in the overall cycle of the steroid hydroxylation reaction, shown 
in Figure 2, must ultimately rest with the nature and the electronic. structure 
of the prosthetic group of the heme protein P450 and, in particular, with the 
nature of one or, perhaps, even both axial ligands. 
The results of a variety of model studies in our; as well as many other 
laboratories, suggest that the prosthetic group of P450(Fe3+), S = 1/2, consists 
of protoheme IX to which a thiol-ligand (as Rs-, most likely) and an aromatic 
N-containing ligand are complexed to the Fe'3+ in the axial 5- and 6-position, 
respectively. Returning to the reaction cycle of Figure 2, we realize that the 
heme protein undergoes a series of changes of its formal valence state, as well 
as its coordination around the Fe. A thorough understanding of the chemical 
nature of each of these participating forms of the heme protein and their 
physical properties becomes essential for our understanding of the reaction 
mechanism of mixed function oxidation (monoxygenation). 
Preparation of the Heme Protein P450 jrom Adrenal Cortex 
Mitochondria 
The heme protein P450 is isolated from bovine adrenal cortex mitochondria 
by the method described in ref. 30. The most crucial steps in this procedure are 
found in the combination of a lyophilization process with a subsequent 
solvent treatment. Following this, the heme protein P450 is extracted in a 
fractional extraction process with the non-ionic detergent Triton N-101 (a 
rionyl-phenylpolyoxyethylene-ether with average molecular weight - 640) in 
concentrations ranging from 0.002;0/o up to 1.00/o (w/v). Further steps include 
precipitation with ammonium sulfate, dialysis and/or ·ultrafiltration, and, as 
necessary, gel filtration (on Sephadex G-100) and anion exchange chromato-
graphy (on DE-52). 
In the course of the preparation procedure a considerable amount of cho-
lesterol is removed; under favourable conditions, the molar ratio [cholesterol/ 
heme protein P450] is reduced from an initial value of 140 in the adrenal 
mitochondria to a value of 0.3 in the purified P450 preparation. The contents 
of neutral and phospholipids are also drastically decreased, although not to 
the extent to which cholesterol is removed. (Complete removal of lipids is 
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usually not attempted in order to avoid exposure of the heme protein to possibly 
damaging experimental conditions!). 
The clear brown solutions obtained by this method are indefinitely stable 
on storage in the frozen state. They can be kept as solutions in the cold room 
for 1-2 weeks with little loss of P450; the main product of the then observed 
slow degradation process is a »P420-type material« (note 3) (cf. below; see also 
footnote (4) in ref. 30). 
The preparation is catalytically active in steroid llB-hydroxylation. 
Measured in the optimally reconstituted steroid llB-hydroxylase system (con-
taining heme protein P450, adrenal ISP, and adrenal Fp in a ratio ~ 1 : 20 : 1), 
cleoxycorticosterone is hydroxylated with typical »turnover numbers« of 
5-10 min-1 (i.e. moles product formed/mole heme protein x min) at 25 °c. 
The same preparation is also active in the »Side chain cleavage reaction« of 
cholesterol and cholesterol derivatives (see ref. 36) with typical turnover 
numbers of 2 min-1 at 23 °c. 
Properties of the Adrenal ?450 
The heme protein P450 is isolated as a Fe3+-complex in low spin form, 
P450(Fe3+), S = 1/2 (see note 2 for notation). The optical absorption spectrum 
shows maxima at 277, 365, 416, 535, and 570 nm. The EPR spectrum (X-band at 
77 K) is characteristic of a species with rhombic (i. e. less than ·axial) symmetry 
of a comparatively small anisotropy. The principal components of the g-tensor 
(approximately 1.91, 2.24, and 2.42) are easily derived from the observed 
random orientation spectra. These values differ substantially from those of 
other known Fe3+-heme proteins of biological importance (cf. Table I). 
TABLE I 
EPR Spec tra of heme pr oteins 
Heme protein Sourse g- tensor 
gl g2 g3 
P450, s 1/2 adrenal 1. 91 2. 24 2.42 
P450 CAM, s 1/2 Pseud . putida 1. 91 2. 26 2.45 
hemoglobin · OH human 1. 85 2.17 2 . 55 
cytoch.rome c OH horse heart 1. 80 2.19 2. 52 
cytochrome c peroxidase yeast 1. 78 2.2D 2. 75 
hemoglobin N3 human 1. 67 2. 26 2.80 
cytochrome b5 rat liver 1.47 2. 26 2. 95 
cytochrome c bovine 1. 24 2. 24 3.06 
P450CAM, s 5/ 2 Pseud. put id a 1. 8 4. 0 8 . 0 
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The .preparation from adrenal cortex mitochondria does not contain any 
other types of heme proteins. It usually contains however small amounts of a 
»P420 type material« (note 3) which originates, as a degradation product, 
from the heme protein P450 during handling and storage. As a second para-
magnetic contaminant we find some rhombic high spin Fe3+-species which 
gives rise to an EPR absorption near g ..., 4.26; it is also a breakdown product 
of the heme protein P450. 
The heme group is not rigidly held in the protein and can be easily lost 
even under relatively mild conditions. This explains the origin of the de-
gradation products (P420-type material and the high spin Fe3+-species for 
example) in the preparations. As a consequence of the loss of the heme group 
the intact heme protein P450 is »contaminated« with its own heme-free apo-
protein. This is shown in the often low specific concentrations (nmoles/mg 
protein) of the heme 'protein P450. Such a loss of the heme group has been 
a rather troublesome problem with all mammalian preparations, particularly 
since attempts of re-insertion of a heme group to re-form the heme protein 
P450 have so far been unsuccessful (in contrast to the situation with P450cAM:). 
The adrenal preparation contains, typically, .::::; 210/o of the heme protein 
P450 in a high spin form, P450(Fe3+), S = 5/2, as determined fr~m optical 
absorption measurements in the Soret region and in the so-called charge 
transfer band region around 650 nm, as well as from direct observations by 
EPR spectroscopy. 
The adrenal P450 preparation does not contain detectable quantities of Fp. 
It does, however, have a strong tendency to retain some adrenal ISP which 
is surprisingly difficult to remove, for reasons which are not entirely under~ 
stood. Its presence is easily detected by EPR spectroscopy. 
Reactivities of Adrenal P450(Fe3+) 
In systematic investigations of the nature of the interaction of the heme 
protein P450(Fe3+), S = 1/2, from adrenal cortex with a great variety of che-
mical compounds, including substrates, inhibitors, and many other agents, 
two general types of interactions were found, perturbation reactions and true 
ligand replacement reactions. Of these the first group is vastly more common. 
All known types of P450(Fe3+), S = 1/2, are indeed quite prone to perturbations. 
Examples of both classes of interactions are briefly described here. (Under a 
variety of severe experimental conditions - but occasionally also under some 
rather mild conditions - additional processes occur which ultimately lead to 
the loss of the heme group and destruction of the heme protein. Such events 
are treated here only in special cases, although they are of course of practical 
importance for the handling of P450 preparations.) 
Perturbation Reactions; Optical Absorption Studies 
Among the first cases of interactions which we studied were those with 
steroid substrates (deoxycorticosterone and some related molecules) and the 
products of 11~-hydroxylation. Interaction of the heme protein P450(Fe3+), 
S = 1/2, from the adrenal cortex with deoxycorticosterone (DOC) (note 1) -
in ethanol or some other suitable solvent - leads to comparatively small 
changes in the optical absorption spectrum - barely noticeable in the absolute 
absorption spectra but readily measurable by the techniques of difference 
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spectroscopy27• Similar observations were made with a variety of other steroid 
and sterol compounds23, with several inhibitors of steroid hydroxylation21, and 
a great variety of other chemically unrelated compounds which were studied 
for a variety of reasons23,37. 
The interaction of these agents with the heme protein P450(Fe3+), 
S = 1/2, can be conveniently analyzed in terms of the binding of a small 
molecule (such as the steroid substrate) to a macromolecule (i. e. the heme 
protein preparation) based on the theories of ligand binding to multiple, inde-
pendent, and non-equivalent binding sites (cf. ref. 23). In almost all our studies 
of the adrenal P450(Fe3+) we found evidence of heterogeneous binding and 
interaction phenomena; thus, as a general rule, more than one dissociation 
constant, Kd, is required for a satisfactory description of the observed binding 
phenomena. 
For deoxycorticosterone we found a specific high affinity binding site 
(one mole steroid/mole heme protein) associated with a value Kd ~ 2 · 10-6 M 
and an additional, presumably unspecific, second type of binding with a value 
Kd ~ 4 · 10-5 M23• These values have since been confirmed in independent 
equilibrium dialysis measurements on adrenal mitochondria in Vignais's 
laboratory38• 
The Role of EPR Spectroscopy in Perturbation Studies , 
In spite of some instrumental and methodological complexities EPR spectro-
scopy provides us with an accurate sensitive tool for the investigations of 
these interactions. In addition, this method produces results which are - on 
an empirical basis - more directly interpretable than those usually obtained 
in optical absorption measurements (cf. entries in Table I). 
Interaction of adrenal P450(Fe3+), S = 1/2, with perturbation and ligand 
replacement agents (e.g. substrates, inhibitors, other compounds) leads to 
small but again readily measurable effects on the EPR spectra; these effects 
are observable as changes in g-tensor, lineshape and linewidth in the random 
orientation spectra. 
As an example, the interaction of adrenal P450(Fe3+), S = 1/2, with its 
steroid substrate deoxycorticosterone gives rise to a »narrowing« of the aniso-
tropy (Figure 3), which is characterized by a change of the g-tensor as listed 
in Table II. These changes are accompanied by a rather characteristic narrowing 
of the »individual linewidth« of the random orientation spectra (cf. Figure 3) . 
Within the accuracy of the quantitation procedures by numerical integration, 
no loss is observed in the absolute resonance intensity of the EPR absorption. 
As first introduced in 1970 (cf. ref. 27) these results demonstrate that the 
steroid molecule is not entering the coordination sphere of the Fe3+ in the 
heme group by replacement of one of the axial ligands in the 5- and 6-
position (a widely held belief then). Instead, the steroid molecule binds with 
high affinity (Kd ~ 2 · 10-6 M) to a site elsewhere in the protein and, in doing 
so, causes a perturbation of the electronic structure of the heme group nearby. 
It is this perturbation effect which is then detectable by sufficiently sensitive 
spectroscopic techniques. 
Perturbation effects of the magnitude shown here for deoxycorticosterone 
have been observed with a considerable variety of chemical compounds. With 
most of the compounds studied the observed changes in the principal components 
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2 600 2800 3000 3200 34 00 
Figure 3. Interaction of P450 (Fe•+) with steroids and inhibitors of steroid metabolism. 
EPR Spetra (X-band) at 77 K; sample tubes 3 mm i. d. Heme concentration 23 1•M, in 
phosphate buffer (50 mM, pH 7.0). Upper part : Interaction with deoxycorticosterone (final con-
centration 50 µM) . Lower part : Interaction with metopirone, 2-methyl-1,2-bis-(3-pyridyl)-propa-
none-1, final concentration 320 µM. The EPR spectrum of the untreated P450(Fe•+) , S = 1/2, 
recorded under identical instrumental conditions, is indicated by dashed line. The extrema in 
the derivative spectra of treated and untreated samples are marked. 
of the g-tensor were similar in magnitude to those observed with the steroid 
substrates (i.e. < 10/o). True ligand replacement reactions on the other hand 
are associated with much larger effects on the g-tensor - as shown in the 
lower part of Table II (cf. also Table I for comparison with other Fe3+, S = 1/2 
heme proteins). 
Of particular interest in the framework of these studies is the interaction 
of adrenal P450(Fe3+), S = 1/2, with the potent specific inhibitor of steroid 
1 lB-hydroxy lase, metopirone (2-methy 1-1,2-bis-(3-pyridy l-)propanone-1, MP; no-
te 1) . This compound specifically inhibits the llB-hydroxylation of steroids with 
an inhibitor constant Kr< 10-7 M - but has more recently been shown39 to be 
also a useful inhibitor of other P450 mediated oxygenation reactions - albeit 
at usually much higher concentration and with less specificity. 
Interaction of adrenal P450(Fe3+), S = 1/2, with metopirone - at concen-
trations which completely inhibit the steroid 11~-hydroxylation, leads to a 
»widening« of the anisotropy (Figure 3, lower part) and an increase in indi-
vidual linewidth - but again without any detectable loss of total integrated 
resonance absorption intensity. The effects on the g-tensor are marginally larger 
than the ones observed with many of the perturbating agents studied (see 
above), so that an unambiguous distinction between a perturbation effect or 
;i ligand replacement process can no longer be made with certainty (although 
other data suggest that we deal with a perturbation reaction in this case). 
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TABLE II 
EPR Spectra of P450 (Fe'3+) 
Addi tion g-tensor 
g 1 g2 g3 
nr·.1e 1.91 2. 24 2. 42 
ooc 1. 92 2. 24 2.40 
pregnenolone 1.92 2. 2lf 2 .40 
MP 1.90 2. 25 2. 46 
pyridine 1. 88 2. 25 2 . 52 
-F 1.91 2. 24 2. 41 
N; 1. 91 2. 24 2 . 42 
-CN 1.89 2 . 24 2. 50 
-OH 1. 86 2 . 26 2 . 53 
g1 , g2 , and g3 are the principal component s of the g- tensor determined 
from the rec~rded -EPR spectra . All values are rounded to three significant 
digits to simplify the tabl e ; due to the narrow individual linewidth 
observed with P450 (Fe
3
.+) , S =· 1/2, these valUes can usually be measured 
t o±_ O. D0 2 units . 
Ligand RepLacement Reactions 
A direct replacement of one or, perhaps, both of the axial ligands of 
P450(Fe3+), S = 1/2, can be achieved - though usually under more severe 
conditions than those r equired for the perturbations described so far. Several 
examples of such ligand replacement reactions on the heme protein P450(Fe3+) 
have been reported in recent years1,29• Among the reagents which are frequently 
used in studies of heme proteins, NaN3 (at concentrations of up to 1 M) and 
NaF (at concentrations up to 0.5 M) do not react in ligand replacement reactions 
on the adrenal P450(Fe3+), S = 1/2. (This latter observation is of considerable 
diagnostic value also in the case of high spin (S = 5/2) forms of P450(Fe3+) 
wherever they are found (e.g. P450CAM, rabbit liver microsomal preparations) in 
regard to questions about the nature of the axial ligand in the 6-position.) 
As reported earlier1, cyanide ions in high concentration at moderately 
alkaline pH (e.g. 80 mM, pH 10) lead to the formation of an Fe3+ • cy anide 
complex with distinct optical absorption and EPR characteristics (cf. Table II), 
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in which one of the axial ligands is replaced by the cy anide group. This 
P450(Fe3+) · CN complex differs markedly from the corresponding Fe3+ · CN 
complexes of conventional heme proteins such as F e3+-hemoglobin or Fe3+_ 
-myoglobin. 
High concentrations of OH- - ions can be used to replace the (hypothetical) 
thiol ligand of P450(Fe3+), again w ith its own distinct optical and EPR cha-
r acteristics (cf. Table II). 
By appropr iate choice of the experimental conditions one can predict and 
to a certain extent select the ligands which ar e r eplaced in the heme protein 
P450(Fe3+), S = 1/2. This allows alterations , within r easonable limits, of its 
structure. It also permits the development of a homologous series of F e-com-
plexes with distinct identifiable properties, w hich can in turn be compared 
with those of corresp01;ding complexes derived from conventional h eme pr oteins 
(for some r elevant data and examples see r efs. 1 and 40 ; cf. also the data listed 
in Tables I , II, and Table III b elow) . This systema tic experimental approach 
provides good supporting evidence for the proposed hypothetical str uctures of 
P450(Fe3+) and the other important forms of this h em e protein. 
Our studies of the reactivities of P450(Fe3+) have r ecently been extended 
to include a considerable number of other agents such as salts, organic sol-
vents, denaturing agents, and detergents. These studies are carried out to 
p rovide a better understanding of the reactivities of the h eme protein P450 
in soluble form (as with the adrenal preparation) and in membrane-bound 
TABLE III 
b . 2+ A sorpt~on spectra of Fe • I;igand complexes 
Ligand Absorption rnaxima (nm) 
none 411 ( •• , 1+16 ) 550 
02 418 555 580 
co 448 (42l)a 555 
NO 439 (419) b 
OH- 422 526 557 
MP'· 442 (419 ) "525 552 
pyridi ne . (pH. 7) 419 (471)a. 524 556 
pyridine (pH 12.5) 421 (446) a 525 556 
imidazole (pH 7) 426 528 559 
a shoul der ; b diffuse bands 
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forms, in relation to the chemical structure of the heme moiety and to the 
modes of interaction of the heme protein with the membrane structures in 
which it is found. These studies are also of immediate practical importance for 
further improvements in the handling of the various P450 preparations. Many 
of the observed phenomena fit well again into the two classes described, the 
perturbation and, occassionally, also ligand replacement reactions. At higher 
concentrations of the applied agents the reactions become increasingly more 
complex; additional processes occur which often involve the loss of the heme 
moiety. 
Inorganic salts (with the exception of strongly chaotropic agents such as 
NH4SCN) are found to cause only small perturbations of adrenal P450(Fe3+) , 
S = 1/2, which are detected as small changes in the optical absorption spectra 
and small shifts of the g-tensor characteristic for the EPR spectra, which are 
usually smaller than those observed with, for instance, steroids; for numerical 
examples see the »effects« of F- and N3- in Table II - where the observed 
shifts in the principal components are :::; 0.005 units). 
The heme protein P450(Fe3+) is affected by a variety of organic solvents 
(including alcohols, ketones, halo-alkanes, alkanes, and polar solvents such 
as dimethylsulfoxide or N-dimethyl-formamide) . At low concentrations of most 
of these solvents, perturbation effects are seen, of the type and magnitude 
described above. Glycerol, for instance, which is often used as -protective agent 
in solubilized preparations from microsomes, causes minor changes in the 
optical absorption spectra and shifts in the g-tensor of the EPR spectra. In a 
microsomal preparation from rat liver, for example, glycerol (20°/() v/v) caused 
a shift of the »low field« g3-component from a value 2.432 to a value 2.418; this 
shift was accompanied by a decrease of the half-width of the »low field peak« 
from 58 to 38 Oersted. 
Figure 4. shows another example of a solvent perturbation of P450(Fe3+), 
S = 1/2. The concentration of the solvent, pyridine, was deliberately chosen 
9.092 GHz 
2200 2600 3000 3400 3800 
H 0 Oersted 
Figure 4. Interaction of P450(FeS+) with pyridine. 
EPR spectrum at 93 K; microw ave power 20 mW. The principal components of the g-tensor 
are listed. The set (1.920, 2.25, 2.432) belongs to unreacted - but perturbed - P450(FeS+j, S = 1/2. 
The set (1.884, 2.25, 2.518) with larger anisotropy and broader »individual« linewidths b elongs to 
the Fe•+-pyridine complex (cf. also Table II) . 
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so that the two species, the native and the perturbed heme protein are seen 
side by side. 
Several of the solvents studied produce, at moderately high concentrations, 
an irreversible conversion of the heme protein P450 to a »P420-type material« 
(note 3). In comparative studies of homologous series of such solvents (e.g. of 
alcohols) we found that the nature of the alkyl group in the alcohols determines 
largely the magnitude and extent of these destructive effects, presumably via 
a localized »microsolubility« of the solvent in the protein environment of the 
heme moiety rather than a direct attack on the heme moiety. Several ketones 
examined show similar effects but also prove to be good solvents for the heme 
moiety; in essence they destroy the preparation by extraction of the heme 
group. This last mentioned effect is, for example, observed as a complicating 
factor in some studies with 2,2-dimethyl-butanone; the observable perturbation 
effects on the heme group, which are similar to those observed with metopirone 
(cf. Table II) are partially obscured by these extraction effects. 
The interaction of P450(Fe3+) with detergents plays a rather important 
role, as all mammalian types of the heme protein P450 are found in vivo in 
membrane-bound form: in organelles (as in adrenal mitochondria) or in intra-
cellular structures (as in the endoplasmic reticulum). To obtain a workable 
solubilized preparation the heme protein must be released from the membrane 
structures by suitable techniques which in most cases include the application 
of a detergent. (It is conceivable that even in microorganisms the heme protein 
P450 may be bound to small intracellular structures - although no clearcut 
evidence is available as yet.) -
In our experience the non-ionic detergents of the poly-oxyethylene-type 
have shown the best results, combining good solubilizing properties with 
minimal perturbation and/or damage to the heme protein P450(Fe3+) regardless 
of its source (adrenal mitochondria, as discussed here, adrenal microsomal 
preparations, microsomal preparations from endoplasmic reticulum of other 
tissues). We routinely use Triton N-101 in our preparation methods (cf. com-
ments in ref. 30). Other preparations of the Triton N- and X-series and analogous 
products of other manufacturers are also relatively inert to the heme protein 
and its enzyme activity if used at reasonably low concentrations; they perform 
nearly as well. It is perhaps for this reason that several laboratories have 
recently replaced their previously used detergents by some of these non-ionic 
detergents. Unless unnecessarily high concentrations, well above the critical 
micelle concentration, are used the perturbation effects of Triton N-101 (and 
similar non-ionic detergents) are again quite small (for an example see ref. 41). 
Excess amounts of these detergents used during extraction procedures can be 
removed by suitable chromatographic procedures - although with some dif-
ficulties; the remaining small amounts do not affect negatively the chemistry 
of the heme group or the enzyme activity in steroid HB-hydroxylation. 
As a representative of the large group of ionic detergents we have studied 
in greater detail the interaction of P450(Fe3+) and of the other forms of the 
heme protein with sodium dodecyl sulfate (SDS) (note 1). SDS at concentrations 
well below the critical micelle concentration converts irreversibly P450 to a 
»P420-type material« (note 3); treatment with low concentrations of SDS 
provides in fact a useful practical method for such a conversion in the labora-
tory. What is observed with higher concentrations ·of SDS - beyond this 
conversion to a »P420-type material« - depends very much on concentration 
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o~ the detergent, duration of exposure, temperature, pH etc. Applying in 
systematic studies SDS over a range from well below the critical micelle con-
centration to concentrations much higher than this critical value (e.g. 1-3°/o 
SDS in aqueous solution) the full range of effects can be observed, ranging 
from minute perturbations of P450(Fe3+), S = 1/2 (but with the above-mentioned 
effect on the Fe2+ • CO complex) to increasingly drastic alterations of the heme 
group (as seen by EPR spectroscopy) as the detergent concentration is raised, 
and eventually the irreversible loss of Fe and the heme moiety from the 
protein (for further details see refs. 41 and 42). 
As a final example of the reactivities of P450(Fe3+) we have briefly sum-
marized a few results of studies of the »pH dependence« in Figure 5. Solutions 
of adrenal P450(Fe3+), S = 1/2, were brought to the desired pH value using 
a series of overlapping buffer systems to cover an overall pH r ange of 
< 3 to> 13 (see refs. 41 and 42) . (Addition of small concentrations of detergents 
was necessary in the pH range 4.5-6 to keep the protein in solution). The 
' 
EPR - Absorption ®.J\ @ ..... ~ y fa\,., /V(,._,. 
f~sJ 
1•2?} 1.92 1.68 
9 ... tensor -2.08 2.25 2.25 
5.8 2.43 2.52 
Spin state 5= 5/2 s = 112 5. 112 
Olfical AbSO(Jltion ), max l Soret-Rltg1on l 
Fe" 393 416 417 418 405 
Fe2" 396 411{···l.17J 422 423 l.18 , 428 
Fe~"co 403 448 421 420 14181420 
1 3 5 7 9 11 13 
PH-
Figure 5. pH Dependence of spectral properties of adrenal heme protein P450(Fe•+) and related 
FeH-forms. 
spectral characteristics of the reaction products were determined by optical 
absorption spectrophotometry and, after freezing in liquid nitrogen, by EPR 
spectroscopy. The studies were extended to cover the properties of the reaction 
products after reduction to the corresponding Fe2+ complexes, in absence or after 
addition of a suitable ligand (CO in the summary of Figure 5). These investigat-
ions have provided valuable information about the reactivities of P450(Fe3+) 
- either directly or in comparison with corresponding observations of pH 
dependence and ligand chemistry of other more conventional heme proteins. 
Results of these investigations, together with those of ligand replacement 
reactions, provide strong support for the proposed structure of P450(Fe3+), 
S = 1/2, with a thiol- and an aromatic N-containing group (such as a cysteine 
and a histidine) respectively; see also refs. 1 and 41 for further details. 
Reactivities of Adrenal P450(Fe2+) 
The second form which the heme protein P450 assumes in the course of 
the reaction cycle of steroid 11~-hydroxylation (Figure 2) , of camphor hydroxyl-
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ation9 and, by analogy, also of other monoxygenase reactions, contains the 
metal ion in a formal 2 + -valence state, as P450(Fe2+) (notes 1 and 2). 
P450(Fe2+) is readily obtained by reduction (chemical or enzymatic, in 
presence of the then necessary cofactors) according to equation (2) 
(2) 
in a fully reversible one electron reaction25•2s. The redox potential of the 
Fe3+/Fe2+ - couple of adrenal P450, in the absence of any ligands, was measured 
as 
E 0 ' = -400 mV ± 10 mV 
at 25 °C and pH 7.0. The reduction follows strictly a first order rate law2S with 
a second 01·der rate constant of the order of k ~ 25 ~1 s-1 at 25 °C. The rate 
of reduction is thus qqite slow; it is very little influenced by addition of steroid 
substrates or related compounds. 
Indirect kinetic evidence29 suggests that in spite of the simplicity of the 
overall reaction as written in equation (2) the reduction of P450(Fe3+) is actually 
a complex process and involves at least one additional reaction step which is 
found to be first order with time and first order with the heme concentration. 
This latter process may represent the change of coordination of the Fe in the 
heme group which is associated with the reduction process (direct spectroscopic 
evidence is, however, still lacking). 
Reduction to P450(Fe2+) involves a change in coordination from the hexa-
-coordinated P450(Fe3+), S = 1/2, to what appears to be a penta-coordinated 
high spin P450(Fe2+), S = 2. Support for the high spin nature of P450(Fe2+) 
comes from a comparison of its properties with those of the spectrally and 
chemically identical P450CAM(Fe2+) for which Mi:issbauer spectroscopy and, even 
more convincingly, high resolution NMR spectroscopy have unambiguously 
demonstrated such a structure9• 
P450(Fe2+) exhibits some unusual and atypical features in its optical ab-
sorption spectrum. In comparison with P450(Fe3+), S = 1/2, the spectrum of the 
Fe2+-form shows a blue-shifted broad absorption band in the Soret region, 
with a maximum at 411 nm in the preparations which are free from any 
»P420-type material«, and an unstructured broad band near 550 nm (cf. 
Table III). The position of the absorption band in the Soret region is very 
sensitive to the presence of even small amounts of other heme proteins in-
cluding any »P420-type material« (note 3) (which exhibits a sharp narrow 
absorption band at approximately 420 nm). Both the position and the height 
of the Soret absorption band can serve as a sensitive criterion for the purity 
of the P450 preparations and an empirical measurement for its contamination 
with »P420-type material«. P450(Fe2+) has not been detected by EPR spectro-
scopy. 
P450(Fe2+) reacts readily with a variety of molecules to form diamagnetic 
Fe2+ · Ligand complexes (cf. Table III). All the reactions studied so far are 
reversible. Among the compounds which react with P450(Fe2+) are small gaseous 
ligand molecules, such as oxygen, (its physiological reactant in the hydroxylat-
ion reaction), carbon monoxide (which provides the most important analytical 
tool), and nitric oxide (which is of considerable theoretical interest. for the 
coordination chemistry and of practical importance as a paramagnetic probe 
of the environment of the heme group, especially in membrane-bound forms). 
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Many larger lipophilic molecules - including pyridine- and imidazole-
-derivatives, other heterocyclic compounds, haloalkanes, organic hydroperoxides 
- bind readily to P450(Fe2+), with often high affinitiess7,4a_ Many of these 
agents cause only perturbations when they interact with P450(Fe3+), S = 1/2 
- as briefly described in the preceeding section. With P450(Fe2+) these agents 
tend to enter the cooordination sphere of the Fe and to form rather stable 
Fe2+ · Ligand complexes with often distinct optical absorption (e.g. 440-470 
nm in the Soret region; cf. also Table III) . 
The binding equilibria for a considerable variety of such liganding agents 
were measured for the adrenal P450(Fe2+} and, in comparative studies, also for 
a selection of membrane-bound forms of P450(Fe2+). Solutions of the ligands 
were equilibrated with P450(Fe2+), after chemical or enzymatic reduction, in 
especially developed anaerobic cuvettes under strict oxygen exclusion; ligand 
concentrations were varied r6utinely up to 104-fold. A special technique was 
developed which allows direct equilibration with gaseous ligands diluted in 
inert carrier gas. The Fe2+ · Ligand complexes were studied by optical absorption 
techniques. -
Reaction of P450(Fe2+) with 0 2 
The adrenal P450(Fe2+) reacts readily with molecular 0 2 to form a reason-
ably well defined diamagnetic oxygen complex, P450(Fe2+)' · 0 2 as reported 
earlier23,29, either directly or by replacement of another ligand from a 
P450(Fe2+) · Ligand complex (for example CO). The P450(Fe2+) · 0 2 complex 
exhibits an absorption spectrum with a maximum at 418 nm in the Soret region 
and rather diffuse broad bands at 555 and 580 nm, thus presenting a remarkable 
similarity with other Fe2+ · 0 2 complexes of heme proteins (as discussed in 
ref. 29; cf. 1. c. Table I). The Fe2+ · 0 2 complex is spectrally and in its general 
properties, identical with the P450CAM(Fe2+) · 0 2 observed by Gunsalus and 
collaborators8 and by Ishimura et al.44 with P450CAM from P . putida. No evidence 
is found with adrenal P450 preparations of any 440 nm absorbing species in 
either absolute or difference spectra. 
P450(Fe2+) · 0 2 prepared from the adrenal P450 preparation in absence of 
adrenal ISP is rather unstable and decays in a spontaneous reaction, rapidly 
forming P450(Fe3+), S = 1/2. This process is dramatically speeded up by even 
traces of the adrenal ISP as well as by viologen dyes. It is for this reason that 
only the wavelengths of maximal absorption of P450(Fe2+) · 0 2 have been 
determined with accuracy (see entry in Table III). The molar absorption coef-
ficient at 418 nm has been estimated, by extrapolation to zero time, as e418 nm ,..., 
,..., 6.7 · 104 M-1 cm-1• 
To provide satisfactory chemical evidence for the nature of the spectrally 
detected Fe2+ · 0 2 complex detailed studies were undertaken in which we 
attempted to utilize this complex in steroid hydroxylation. On the basis of 
preliminary studies the following procedure was developed: Suitable quantities 
of adrenal P450(Fe3+), saturated with radioactively labelled 14C-DOC as sub-
strate, were reduced by stoichiometric reductive titration with sodium dithionite 
in a closed vessel under strict exclusion of 0 2 • In a separate vessel, adrenal ISP 
in appropriate quantities was reduced by the same technique. Progress of the 
reduction was followed spectrophotometrically. 
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From the stable P 450(Fe2+), saturated with substrate, the oxygen complex 
was prepared by either direct gassing or by addition of oxygen-containing 
buffer solut ion , fo llowed by brief purging with oxygen-free carrier gas. Im-
mediately thereafter , the reduced ISP was transferred and rapidly mixed 
with the substrate-saturated P450(Fe2 ' ) • 0 2 • The reaction mixture was im-
mediately extracted with cold CH2Cl2 . The hydroxylated product formed 
in this r eaction w as separated from the unused substrate by thin layer chro-
matography on silical gel, using a CHC13 /CH30H/H 20 solvent mixture. The 
amount of product formed was determined by a combination of several methods 
including radio-scanning, optical densitometry of the TLC plates, and scintil-
lation counting of the scraped-off material. 
An example of such an experiment is given in Table IV. The reaction of 
P450(Fe2+) · 0 2 with an equimolar amount of reduced adrenal ISP in presence 
of an excess of DOC as.substrate leads to the formation of the llB-hydroxylated 
product with a nearly stoichiometric yield ; the experimental conditions chosen 
do not allow any »turnover« of either the heme protein or the ISP. P ar allel 
experiments with other heme proteins did not lead to product formation, nor 
did we obtain significant quantities of product when the adrenal ISP was 
replaced by a redox dye of comparable redox potential (i. e. benzylviologen). 
The yield of product formation (stoichiometric with the applied concentration 
of P450(Fe2+) · O z) was not increased by the addition of larger quantities of 
reduced ISP. Without r eduction, the adrenal ISP proved ineffective. 
These results demonstrate that the oxygenated P450(Fe2+) · O z and the 
reduced adrenal ISP are the only required components, sufficient to carry out 
steroid llB-hydroxylation in a strictly stoichiometric reaction (which represents 
the final step of the reaction cycle shown in Figure 2) . 
By carrying out the steroid llB-hydroxylation as stoichiometric reaction 
between only two reactants, we have avoided most of the complexities of 
measurement and interpretation of kinetic studies on this multienzyme system 
TAB LE IV 
Enzymatic hydroxylation o.f deoxycorticoster one (DOC) 
2+ 
.P450(Fe ) · O~ + ISP d ,;· r e 
Conditions Expt . lli3- 0H- OOC 
. Before mixing 1 0. 0 ·nmoles 
After mixing 1 20 , 5 nrnoles 
2 20 .7 nmoles 
ooc 
605 nmoles 
583 nmol es 
579 nmol es 
RPaction mixture : 21 . 0 runoles P450, 21 . 2 runoles I SP 605 runoles' 
I 4 ' . ·- (1.58 C/rrole) OOC (4- C) , 50 mM phosphate, pH 7 . 0 , 
I final volurre 2. 66 ml . · 
Isolated material: from TLC- pl ates , Si lica Gel F 254 . 
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(cf. also ref. 45). The same procedure is applicable to the P450CAM system - but 
cannot, unfortunately, be applied to P450 mediated monoxygenation reactions 
with P450 from the endoplasmic reticulum. 
The nearly stoichiometric yield of product formation under »no turnover« 
conditions proves the correctness of the assigned chemical structure for the 
418 nm absorbing species. Furthermore, the stoichiometric hydroxylation 
reaction allows a direct measurement of the catalytic capabilities of the heme 
protein P450 preparation - a measurement which cannot be made by any 
kinetic method, which will always result in a product [turnover number x 
active fraction of the enzyme]. The results show that virtually all of the heme 
protein P450(Fe3+), S = 1/2 isolated from the adrenal cortex mitochondria is 
indeed catalytically fully active. They also show clearly that a high spin 
form, S = 5/2, of P450(Fe3+) is not an absolute requirement for steroid 11B-
-hydroxylation. However, conversion of P450(Fe3+) from a S = 1/2 form to a 
high spin S = 5/2 form - where, and to the extent to which, it occurs - may 
well be important for certain types of reactions. It may for example influence 
the rate of reduction of the Fe3+ heme protein by the first reducing equivalent 
of the reaction cycle. 
Reaction of P450(Fe2+) with CO 
The complex formation of P450(Fe2+) with carbon monoxide has been 
essential for the discovery of the heme protein15- 17. Today, P450(Fe2+) · CO still 
provides a unique tool for all studies of the heme protein P450 and its assay. 
P450(Fe2+) · CO is readily formed by combination of the »unliganded« P450(Fe2+) 
with carbon monoxide; alternatively, it can be formed by replacement of less 
strongly held ligands in P450(Fe2+) · Ligand complexes. 
Carbon monoxide has - like oxygen - a high affinity for the heme 
protein P450, but only a limited amount of quantitative data for the CO 
affinity of different P450 preparations are available at present. In the frame-
work of some detailed reactivity studies37 we have compared the CO affinity of 
our adrenal P450(Fe2+) with a large variety of microsomal preparations from 
rat liver. Figure 6 shows an example of such measurements on the adrenal 
P450(Fe2+) · CO. In these measurements we have used a specially developed 
spectrophotometric procedure, in which the heme protein is equilibrated with 
a mixture of carbon monoxide with an inert oxygen-free carrier gas; the 
concentration of CO is controlled by the composition of the gas mixture which 
is prepared by a set of accurately calibrated gas metering pumps operated in 
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Figure 6. CO Affinity of adrenal P450(Fe2+). (For experimental details see text). 
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tandem. As seen from Figure 6 binding of CO to the adrenal preparation 
follows closely an ideal behaviour; half-maximal saturation is obtained with 
a gas mixture containing on the order of 0.01 vol-0/o of CO. Figure 6 also includes 
results obtained with a »P420-type material« which is formed as a degradation 
product of adrenal P450. Similar measurements were carried out over a wide 
range of experimental conditions varying temperature, pH (cf. Figure 5) and 
other parameters. (For some related aspects see also ref. 46). 
Re1action of P450(Fe2+) with Pyridine Derivatives 
Unlike the case of its interaction with P450(Fe3+) described above, meto-
pirone, MP, binds readily to the heme protein in its ferrous form, P450(Fe2+), 
to form a complex with maxima at 442 nm, 525 and 552 nm; its spectrum 
resembles that of a pyridine hemochrome type complex (see also ref. 23). (It 
should be noted that even at high concentration a mixture of two different 
species is formed; the nature of this complexity - resembling somewhat the 
earlier observations with isonitriles - is as yet not completely understood.) 
A spectrally similar complex of P450(Fe2+) with MP is also obs~rved with 
various membrane-bound forms. However, large differences in reactivity 
towards MP (and similar agents) are found with various types of microsomal 
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Figure 7. Binding of metopirone to P450(Fe'+) in microsomal preparations from rat liver. 
Open squares (and fitted solid line) were obtained with a microsomal preparation frnm 
phenobarbital (PB)-treated Sprague-Dawley rats; open circles (and dash ed line) show results 
with a microsomal preparation from 3-methylcholanthrene (MC)-treated animals, obtained 
under identical experimental conditions. The fractional saturation a. is plotted as a function 
of the free ligand concentration. 
results of a titi;ation experiment on a microsomal preparation from phenobar-
bital (PB) treated mature Sprague-Dawley rats. The measured fractional 
saturation a follows closely an ideal binding behaviour with one binding site; 
some evidence for additional unspecific binding is only detected at much 
higher concentrations of MP. In the parallel experiment with microsomes from 
3-methylcholanthrene-treated rats no evidence of MP binding is detected 
in this concentration range; to observe binding to these MC-microsomes the 
concentration of MP must be increased by 1-2 orders of magnitude. Vastly 
different behaviour of this kind in ligand binding studies is, in a first ap-
proximation, not due to characteristic differences in the nature of the heme 
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protein, but depends on »microsolubility« and binding of the ligands at other 
unspecific binding sites in these membrane-bound preparations, which may 
limit the concentration of the ligand available for binding at the heme site. 
In view of these rather troublesome - and not always recognized -
problems the measurement of the affinities of small neutral molecules to 
P450(Fe2+} becomes of special importance, as they may be less susceptible' to 
unspecific binding in the membraneous structures (for some related comments 
and results see ref. 46). 
Pyridine itself binds readily to P450(Fe2+} at neutral pH (for spectral data 
see Table III) . Related interactions with the heme protein in its ferric form, 
P450(Fe3+), are much more complex; (see Figure 4 for one example) and involve, 
with higher pyridine concentrations, some rather interesting intramolecular 
redox processes which cannot. be described here (but see ref. 43). 
Reaction of the Heme Protein P450 with Nitric Oxide (NO) 
Nitric oxide, NO, with its unpaired electron introduces a S = 1/2 spin 
system into the otherwise EPR undetectable P450(Fe2+} as it forms a tightly 
bound NO-complex. Equilibration of a P450(Fe2+) · Ligand complex with NO 
also leads to the formation of a Fe2+ • NO complex; the - at least partial -
reversibility of the latter reaction 
P450(Fe2'} • CO + NO :;::>: P450(Fe2' ) • NO + CO (3) 
has been important in demonstrating the nature of the observed reaction 
products47. It is of interest that a Fe2+ • NO complex can also be obtained by 
reaction of P450(Fe3+), S = 1/2, with NO gas; no intermediate Fe3+ • NO 
complex could be detected as yet. Its EPR spectrum is presented in Figure 8, 
showing the characteristic partially resolved nuclear hyperfine interaction 
with nitrogen. The (empirical) studies of details of these EPR spectra47 provide 
an exceedingly sensitive tool to probe the microenvironment of the heme 
moiety of the heme protein P450, particularly in membrane-bound forms. 
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Figure 8. Reaction of P450(FeS+) with nitric oxide (NO). EPR spectrum. 
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Reaction of the Heme Protein ?450 with Hydroperoxides 
Extending our earlier EPR studies on Fe3+-peroxidases, we were in-
terested in possible interactions of P450(Fe3+) with H 20 2 and certain organic 
hydroperoxides. These studies were further stimulated by the observations 
that a hydroxylation or dealkylation reaction by certain microsomal preparat-
ions can be supported by the use of organic hydroperoxides. 
Titration of adrenal P450(Fe3+), S = 1/2, with hydroperoxides, at near 
stoichiometric ratios of H 20 2 or ROOH to heme, does not lead to significant 
changes in the optical absorption spectrum - except for small perturbation 
type changes. For an example see Figure 9, in which cumene hydroperoxide 
was used; H 20 2 gives essentially the same results. That the hydroperoxide -
at least with the cumene hydroperoxide - did reach the h eme site under these 
conditions was ascertained by observing the r esulting perturbation in EPR 
spectroscopy. However , as the ratio ROOH to heme is increased, progressivly 
larger changes are seen which can be identified as resulting from oxidative 
heme breakdown (by analysis of the optical spectra as well as from parallel 
studies by EPR spectroscopy) . These destructive processes are relatively slow 
with characteristic time scales of several minutes. Similar observations are 
made with microsomal preparations from rat liver. 
Figure 9. Reaction of adrenal P450(Fe•+) with cumene h y droperoxide. Optical absorption spectra 
(excerpts showing the Soret region only) from a titration experiment. 
In contrast, we observed that the ferrous heme protein, P450(Fe2+), does 
react with H 20 2 or organic hydroperoxides to produce spectroscopically distinct 
species which are relatively stable. Figure 10 shows an example of such studies 
with Hp2 • The solid line (trace 2) is that of the reaction product of adrenal 
H ,0 2 with adrenal P450(Fe2+) in a molar ratio of 2/1; it shows a small shift in 
the wavelength of maximal absorption in the Soret region accompanied by a 
decrease as compared to the spectrum of unreacted P450(Fe2+). The dotted line 
(trace 3) shows the result of equilibration with carbon monoxide. The product 
formed is clearly that of P450(Fe2+) · CO. However, it should be noted that, 
compared with the untreated material, some conversion to a »P420-type ma-
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Figure 10. Reaction of adrenal P450(Fe'+) with H ,o ,_ Optical absorption spectra. 
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Trace 1 (dashed line): P450(Fe2+); Trace 2 (solid line): P450(Fe'+) + H 20 2 in a molar ratio 
1 : 2; Trace 3 (dotted line): same sample, after equilibration with caTbon monoxide. (For further 
details see text.) 
interaction of P450(Fe2+) with hydroperoxides is currently being further in-
vestigated. 
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NOTES 










NADPH-P450 reductase from bovine adrenal glands; 
the iron sulfur protein from bovine adrenal glands; 






thin layer chromatography. 
2. Throughout the text the following notation is used for a definitive description of 
the heme protein in its various forms and states: 
P450 describes the heme protein as a chemical and catalytic entity; a suffix is 
added as necessary to indicate the source from which it is derived (preferably, such 
information is given in the accompanying text) . P450CAM, for instance, refers to the 
camphor-bound or - free forms of the heme protein from Pseudomonas putida9. 
The formal valence state of the metal ion is indicated in parentheses, as P450(Fe3+) 
or P450(Fe2+). Where necessary, the spin state of the heme group is indicated by listing 
the effective spin quantum number S, as in: P450(Fe3+), S = 1/2. The coordination 
around the metal ion is described by a coordination number N (e.g. P450(Fe2+), S = 2, 
(N = 5)). Important ligands are also specified as necessary; P450(Fe2+) ·CO, for example, 
defines the CO complex of the heme protein P450 in the Fez+ valence state. 
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3. The term »P420-type material« does not necessarily describe one chemically defined 
compound; in many instances, however, the term is used here for a breakdown 
degradation product of P450 (the Fe, · CO complex of which absorbs maximally near 
420 nm in the Soret region). Cf. also ref. 30, footnote (4). 
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DISCUSSION 
s. MariciC: 
The curve for pyridine binding looked hyperbolic, but was there a sigmoidal one 
for the CO-saturation? 
H. Schleyer: 
The reversible binding of CO to our P450 preparation corresponds to the ideal case 
of an one ligand, one site equilibrium (i. e. rectangular hyperbola on a Y vs.[CO] plot; 
the abscissa in my slide was logarithmic). I might add, that we looked more closely 
into these binding characteristics of CO - as a small neutral diatomic molecule -
in attempts to minimize the role of unspecific binding processes in membrane-bound 
forms of P450-Fe2+ in rat liver microsomes. Most microsomal preparations from both 
control and phenobarbital induced animals closely followed the pattern given by 
our adrenal P450, thus confirming the validity of the general idea. We have so far 
found only one exception with rat liver microsomes, after a special type of induction; 
in that case a decreased slope around the inflection point of the Y = f (log CO) 
function could readily be assigned to heterogeneity of P450 in these preparations. 
M. J. Coon: 
Does hydroxylation activity in your reconstituted system require phospholipid? 
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H. Schleyer: 
The answer is »no «. We do not have to add phospholipids to restore enzyme activity 
in our reconstituted adrenal steroid hydroxylase system. Addition of phospholipids 
is also not required in the stoichiometric hydroxylation experiments with P450(Fe2+) • 
· 0 2 and reduced iron sulfur protein as the only r eactants; a stoichiometric product 
formation is observed in these experiments. However, I should stress that our P450 
preparation contains some residual lipids and phospholipids which have not been 
removed in the course of the solvent treatment for removal of cholesterol. We have 
made little effort as yet to remove these residual lipids. Strictly speaking, . the pos-
sibility that these phospholipids may play some role in enzyme activity cannot be 
ruled out. 
J. I. Mason: 
Your adrenal mitochondrial cytochrome P450 preparation can exibit both llB-hydro-
xylase and ~holesterol side-chain cleavage activity. What are the relative amounts 
of these P450s and how are these quantitated? The presence of cholesterol side-chain 
cleavage P450 should influence the numbers obtained w hen the stoichiometric turn-
over of P450, iron-sulfur protein and deoxycorticosterone give corticosterone? 
II. Schleyer: 
Our P450 preparation from adrenal cortex has, typically, the following activities in 
optimally reconst ituted systems (with ISP/heme protein ratio of the order , of 20): 
reaction 
llB-hydroxylation of deoxycorticosterone 
side chain cleavage of cholesterol and 
cholesterol-derivatives 
»turnover number« 
moles product/(mole P450 · min) 
10 min-1 (or higher) , at 25 °c 
- 2 min-1 (at 23 oq 
(All our cholesterol measurements were obtained by Shlomo Burstein and his as-
sociates in New York, in close collaboration with our laboratory). 
For a variety of (non-scientific) reasons we have not been able to extend the method 
of »stoichiometric hydroxylation reaction« to the side chain cleavage system as yet, 
but we hope to accomplish this in the not too distant future . As you know, we 
maintain by our preparation method a nearly constant r atio of llB-hydroxylase 
activity to side chain cleavage activity throughout all the steps. 
I. C. Gunsalus: 
Dr. Mason, does your steroid side chain cleavage enzyme system carry llB-hydroxy-
lase activity? 
J. I. Mason: 
No. 
I. C. Gunsalus: 
Dr. Schleyer, what is your comment on the K atagiri and associates separation of 
the adrenal llB hydroxylase & side chain cleavage activity? 
II. Schleyer: 
I hope that I have made it clear in my paper that we maintain throughout the 
various stages of our preparative procedure a nearly constant r atio of llB-hydroxy-
lase activity to side chain cleavage activity (each measured with the corresponding 
substrates after optimal reconstitution with iron-slufur protein and flavoprotein). 
We have never been able to obtain a separation of these activities although we are 
- for a number of reasons- actively looking for it. Incidentally, in our preparation 
we maintain a fairly high side chain cleavage activity (- 2 min-1 at 23 °C); this is 
quite a high value in comparison with some of the values reported for side chain 
cleavage enzyme preparations in literature. Regarding your quest ion, Katagiri and 
I have discussed our mutual findings in detail som e time ago. I do not feel that I can 
make any additional specific commets here. (One should perhaps worry about the 
association of the h emeprotein P450 with the »membranes« and the relative ease 
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with which such associatio:!s can be or are broken under the specific conditions of 
a preparative procedure!). I might add that we had operated some time ago with the 
Boyd method, using istooctane as solvent - compari ng notes about a »partial sepa-
ration« of activities in which side chain cleavage activity W'IS moderately well 
maintained while the llp-hydroxylase activity was partially ini!activated. 
D. L. Williams-Smith: 
Is your measured redox potential affected by the presence of substrates or iron-
- sulphur p r otein in any of its oxidation states? If unchanged, how do you account 
for the reducibility of ferric P450 under physiological conditions? 
H. Schleyer: 
(a) We find no effect on the redox potential (with deoxycorticosterone as substrate) 
nor is the rate of reduction Fe3+-+ Fe2+ appreciably affected (see ref. 28) by substrate 
addition. (b) The red0x potential of E0 ' = -100 ( ± 10) mV at pH 7.0, 25 °c, refers 
to the equilibrium 
Fe3+ + e = Fe2+ 
and is measured in the absence of any ligand. In the presence of CO (e.g. 0.9 mM 
under saturating conditions) we then couple in the second equilibrium 
Fe2+ + CO:;=: Fe2• · CO 
which, due to the strong affinity for CO, shifts the overall equilibrium strongly in 
favor of the Fe2+ · CO form. In the physiological situation, the 0 2 acts in an ana-
logous manner as the 0 2 affinity - - although not precisely known as yet for any 
P450 system - is at least as high as t hat for CO. It is thus the high affinity for 0 2 
which makes the reduction possible. 
G.-R. _Janig 
You have mentioned something about the storage stability of soluble P450. I would 
like to ask you what are the conditions for storage and for what duration is the 
material stable? Is rapid freezing with liquid nitrogen possible? 
H. Schleyer : 
Solutions of our adrenal preparation can readily be stored in the refrigarator or 
cold room; they are stable for 1-2 weeks at 4 °c with only a gradual slow conversion 
of P450 into a »P420-type material« and l ittle loss of enzyme activity. We often add 
glycerol (20 v/v 0/ o) to the solution but that does seem to do very little besides 
slowing down the growth of microorganisms. We certainly do not see a tremendous 
glycerol effect on stability as is observed with some microsomal preparations and 
solubilized preparations derived therefrom. In the frozen state at -20 °c or below 
the preparation is stable for several months with no detectable loss of P450 and/or 
enzyme acitivity except for losses associated with repeated freezing/thawing cycles. 
Rapid freezing of the preparation is certainly possible. We have often used prepa-
rations which h ad been stored at -20 °c for one year or more; storage at 77 K 
is even better. 
SAZETAK 
Hemoprotein P450 iz kore nadbubrezne zli.iezde: reaktivnost u feri - i fero -stanju 
H. Schleyer, D. Y. Cooper, 0. Rosenthal i P . Cheung 
Uloga h emoproteina P450 u reakcijskom m ehanizmu hidroksilaci j e steroida 
mote se ovako p rikazati : 
e- +o, e-
P450(Fe3+) ~ P450(Fe2+) ~ P450(Fe2+) · 0 2 ~ P450(Fe3+) 
U tom reakcijskom ciklusu hemoprotein prolazi kroz niz promjena u koordinaciji 
svog zeljeznog iona (redukcijom u »neligandirano« Fe2+ stanje, zatim vezivanjem 
molekule 02, te uvadanjem drugog redukcijskog ekvivalenta vracanjem hemoproteina 
u pocetno Fe3+ stanje). Steroidni supstrati, inhibitori i razlicni agensi vezuju se, 
s velikim afinitetom, na h emoprotein P 450(Fe3+), izoliran iz nadbubrezne zlij ezde 
goveda u niskospinskom stanju S = 1/2, i to na mjesta blizu hem-skupine, ali u 
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pravilu ne ulaze u koordinacijsku sferu zeljeza. To dovodi do promjena elektronske 
strukture koje se mogu slijediti spektroskopskim tehnikama (opticka apsorpcija, 
EPR) u kombinaciji s prikladnim kemijskim metodama. Direktna zamjena liganda 
takoder je moguce. Fero-hemoprotein P450(Fe2+), sa i bez liganda takoder je istra-
zivan. P450(Fe2') se lako spaja s malim ligandima kao sto su 0 2 (418 nm), CO (448 nm) 
i NO. Vece lipofilne molekule (npr. derivati piridina, drugi heterocikli, haloalkani, 
ili hidroperoksidi) vezuju se na P450(Fe2') cesto i s velikim afinitetom. Takvi ligandi 
pretezno ulaze u koordinacijsku sferu zeljeza cineci stabilne komplekse s cesto izra-
zenom optickom apsorpcijom (440-470 nm); opafa se cesto i dodatno nespecifieno 
vezanje. Primjeri za te razne tipove interakcija prikazani su i razmotreni u odnosu na 
hipotetsku strukturu P450(Fe2'), S = 1/2, kao kompleksa protohema IX s tiolnom 
skupinom i skupinom s dusikom kao aksijalnim ligandima. Rezultati tih istrazivanja 
promatraju se i sa stajalista promjena u koordinaciji tijekom reakcije hidroksilacije. 
HARRISON DEPARTMENT OF SURGICAL RESEARCH 
AND 
JOHNSON RESEARCH FOUNDATION 
SCHOOL OF MEDICINE, UNIVERSITY OF PENNSYILVANIA, 
PHILADELPHIA, PA. 19104, U .S.A. 
Prispjelo 30. prosinca 1976. 
